Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
US health insurance is an obstacle to disease-modifying treatments in MS.
The contribution of neutrophils to CNS autoimmunity.
Therapeutic options and management of polyneuropathy associated with anti-MAG antibodies.
The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory.
Prevalence of multiple sclerosis in Iranian emigrants: review of the evidence.
MRI differential diagnosis of suspected multiple sclerosis.
Postural Sway In Persons With Multiple Sclerosis During Passive Heat Exposure: 2018 Board #170 June 2, 2: 00 PM - 3: 30 PM.
Central Nervous System Pathology Progresses Independently of KC and CXCR2 in Globoid-Cell Leukodystrophy.
Redox Events As Modulators of Pathology and Therapy of Neuroinflammatory Diseases.
Transverse Myelitis and Neuromyelitis Optica Spectrum Disorders.
An emerging role for eotaxins in neurodegenerative disease.
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination.
Role of Therapeutic Plasma Exchange in Treatment of Tumefactive Multiple Sclerosis-Associated Low CD4 and CD8 Levels.
Optimizing electrodiagnosis for Guillain-Barré syndrome: Clues from clinical practice.
Targeted suppression of autoreactive CD8(+) T-cell activation using blocking anti-CD8 antibodies.
Leukocyte adhesion molecule dynamics after Natalizumab withdrawal in Multiple Sclerosis.
Erratum: Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis.
Current Evidence Does Not Support Exercise Therapy for Perceived Fatigue in Multiple Sclerosis.
White Matter Tract Injury is Associated with Deep Gray Matter Iron Deposition in Multiple Sclerosis.
Exacerbation of demyelinating syndrome after exposure to wireless modem with public hotspot.
IVIg attenuates complement and improves spinal cord injury outcomes in mice.
Diffusion tensor imaging with direct cytopathological validation: characterisation of decorin treatment in experimental juvenile communicating hydrocephalus.
Zinc transporter 3 (ZnT3) gene deletion reduces spinal cord white matter damage and motor deficits in a murine MOG-induced multiple sclerosis model.
Proteolytic regulation of synaptic plasticity in the mouse primary visual cortex: analysis of matrix metalloproteinase 9 deficient mice.
Trifluoperazine: A Sprightly Old Drug.
Pages
« first
‹ previous
…
800
801
802
803
804
805
806
807
808
…
next ›
last »